Previously, the heart medicine dronedarone received FDA approval "to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter." Dronedarone is marketed to the public as Multaq.
On January 14, 2011, the FDA issued a severe liver injury warning on Dronedarone/Multaq. FDA notified healthcare professionals and patients about cases of rare, but severe liver injury. Two patients have required liver transplants. Information about the potential risk of liver injury from dronedarone is being added to the WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS sections of the dronedarone labels.
If you have taken or are currently taking the heart medicine Multaq to control atrial fibrillation or flutter, contact the law firm of Berger & Lagnese for a free consultation.
Free no obligation consultation with the medical malpractice attorneys at Berger Lagnese, P.C., located in Pittsburgh, Pennsylvania. Call toll-free 1-800-350-6161, or call us from your local number at (412) 471-4300. We are located in downtown Pittsburgh in the Grant Building on Grant Street, directly adjacent to the Allegheny County Court of Common Pleas.
Post a Comment to "Heart Medicine Multaq (Dronedarone) Can Cause Severe Liver Damage"
To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."Berger & Lagnese, LLC
310 Grant Street
Suite 720
Pittsburgh, PA 15219
Phone: (412) 471-4300
Fax: (412) 471-3116
Toll Free: (800) 350-6161
Get Directions